Pmlive

Pmlive PMLiVE.com is the online home to PME, Communiqué and The Directory. Sign-up for online copies: http://www.pmlive.com/register
(1)

Sign-up for online copies: http://www.pmlive.com/register

You can also find us here:
Twitter: https://twitter.com/pmlivecom
LinkedIn: https://www.linkedin.com/company/pmgroup-worldwide-ltd
Google Plus: https://plus.google.com/+pmlivecom
YouTube: https://www.youtube.com/user/PMLiVETV

The PMLiVE website and its associated monthly print magazine Pharmaceutical Market Europe (PME) and twice-yearly p

rint titles Communiqué and The Directory are published by PMGroup. The website offers the latest pharma news, analysis, jobs and events, including the annual Pharmaceutical Market Excellence Awards (PMEAs), Communiqué Awards and the Quality in Care (QiC) Programme.

Moderna’s updated COVID-19 mRNA vaccine approved by MHRA
04/09/2026

Moderna’s updated COVID-19 mRNA vaccine approved by MHRA

The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme

Novartis announces trial results for remibrutinib in relapsing multiple sclerosis
04/09/2026

Novartis announces trial results for remibrutinib in relapsing multiple sclerosis

MS affects nearly three million people worldwide and has three main types

Inventiva appoints Chris Benecchi as Chief Operating Officer
03/09/2026

Inventiva appoints Chris Benecchi as Chief Operating Officer

Benecchi was most recently CEO of Motric Bio

Prescient completes integration of Uptake and Dolon under single global brand
03/09/2026

Prescient completes integration of Uptake and Dolon under single global brand

The rebrand marks the final stage of integrating the three businesses

Lilly to acquire Merida Biosciences in deal worth up to $2.875bn
03/09/2026

Lilly to acquire Merida Biosciences in deal worth up to $2.875bn

The acquisition is to advance treatments for serious autoimmune and allergic diseases

AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab approved in EU as first-line treatment for breast cancer
01/09/2026

AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab approved in EU as first-line treatment for breast cancer

This is the first new regimen in more than a decade for first-line treatment for this type of breast cancer

Why some stories change healthcare and others just generate noise
01/09/2026

Why some stories change healthcare and others just generate noise

In healthcare communications, the value of media relations is not just in getting stories out. it’s in what those stories do once they are there

Supporting the people who support patients
29/08/2026

Supporting the people who support patients

Supporting those who provide care can lead to improved experiences and health outcomes for everyone involved.

Genentech’s US manufacturing facility advances with construction milestone
28/08/2026

Genentech’s US manufacturing facility advances with construction milestone

The facility is part of Roche and Genentech’s broader $50bn commitment to US R&D and manufacturing infrastructure

LEO Pharma elects Henriette Mersebach to the Board of Directors
28/08/2026

LEO Pharma elects Henriette Mersebach to the Board of Directors

Mersebach previously held senior leadership positions at ALK-Abelló and Novo Nordisk

Address

Little Bookham
KT233JG

Opening Hours

Monday 9:30am - 5:30pm
Tuesday 9:30am - 5:30pm
Wednesday 9:30am - 5:30pm
Thursday 9:30am - 5:30pm
Friday 9:30am - 5:30pm

Website

Alerts

Be the first to know and let us send you an email when Pmlive posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category